Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
用户bC01MF19H1nA
4小时前
10
10
待确认
帖子自动结束时间: 2025-06-22 14:02:52
1. 请及时下载文件确认是否正确, 系统将在 2025-06-24 14:28:39 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
P Wangchuk, K Yeshi, A Loukas
Trends in Pharmacological Sciences, 2024
cell.com
Ulcerative colitis (UC) is one of the two forms of inflammatory bowel disease. It affects 5 million people globally, and is a chronic and recurring inflammation of the gastrointestinal tract with clinical presentation of abdominal pain, chronic diarrhea, rectal bleeding, and weight loss. The cause and the etiology of UC remain poorly understood. There is no cure and no
